IGC Pharma (IGC) Net Margin Growth (3y) (2013 - 2025)
IGC Pharma (IGC) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25,551.00 |
| Jun 30, 2025 | 82,618.00 |
| Mar 31, 2025 | 500,828.00 |
| Dec 31, 2024 | 96,509.00 |
| Sep 30, 2024 | 734,040.00 |
| Jun 30, 2024 | 144,781.00 |
| Mar 31, 2024 | 216,277.00 |
| Dec 31, 2023 | -58,878.00 |
| Sep 30, 2023 | 48,333.00 |
| Jun 30, 2023 | -5,161.00 |
| Mar 31, 2023 | -73,436.00 |
| Dec 31, 2022 | -39,765.00 |
| Sep 30, 2022 | -114,417.00 |
| Jun 30, 2022 | -123,005.00 |
| Mar 31, 2022 | -526,911.00 |
| Dec 31, 2021 | -158,742.00 |
| Sep 30, 2021 | -765,122.00 |
| Jun 30, 2021 | -228,744.00 |
| Mar 31, 2021 | -359,045.00 |
| Dec 31, 2020 | -208,100.00 |